Myopia management has developed into a significant segment of clinical practice in recent years. Interventions primarily aim to attenuate the development of refractive error through the slowing of axial growth, either through pharmacological or optical mechanisms. While spectacle lenses represent a relatively immature branch of optical interventions, they are attractive in practice due to ease of implementation and the rapidity with which change or removal from the clinical strategy may be implemented1-3.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
- 11 print magazine issues per year
- Annual wallplanner
- Delivered to your door
Digital: from $40/year +GST
Print + Digital: $110/year +GST (adds print magazine, wallplanner, delivery)
